Return to University Health's Homepage.

Glenn Halff, MD

UT Health San Antonio
Schedule an appointment: 210-743-4306
Loading...
Loading...

Overview

Practice Locations

Insurance

About

Video

Articles & Publications
Specialties
Surgical Critical Care
Transplant
Areas of Interest/Focus
Transplant
Board Affiliation/Certification
American Board of Surgery
Education
University of Texas Hsc-Houston, 1983
Residency
New York University Medical Center, 1988
Fellowships
University of Pittsburgh School of Medicine - GME, 1989
Languages
English
Spanish
Gender
Male

Texas Liver Tumor Center

7979 Wurzbach Road
Suite 219, Urschel Bldg
San Antonio,TX 78229
210-743-4306
Location Details

University Hospital

4502 Medical Drive
San Antonio,TX 78229
210-358-4000
Location Details
Insurance Accepted
6 Degrees - Transplant
90 Degree Benefits - Commercial
Aetna - Commercial Exchange
Aetna - PPO/EPO/HMO/MC Advantage
Aetna - Smart Care EPO
Aetna - Transplant
Aetna Better Health - Medicaid-CHIP
Aetna Better Health - Medicaid-STAR
Amerigroup (Gonzaba) - Medicare Advantage (Transplants only)
Amerigroup - Medicaid-CHIP
Amerigroup - Medicaid-CHIP Perinate
Amerigroup - Medicaid-STAR
Amerigroup - Medicaid-STAR Kids
Amerigroup - Medicaid-STAR PLUS
Amerigroup - Medicare Advantage
Amerigroup - Medicare-Medicaid Duals
Ancira Enterprises - Direct Employer
Blue Cross Blue Shield of Texas - Exchange (BlueAdvantage)
Blue Cross Blue Shield of Texas - HMO/PPO
Blue Cross Blue Shield of Texas - HPN/EPO (Narrow Network)
Blue Cross Blue Shield of Texas - Medicaid-STAR
Blue Cross Blue Shield of Texas - Medicare Advantage HMO
Blue Cross Blue Shield of Texas - Medicare Advantage PPO
Blue Cross Blue Shield of Texas - Narrow HMO (Blue Essentials)
Blue Cross Blue Shield of Texas - Narrow HMO (Blue Premier)
Blue Cross Blue Shield of Texas - Traditional
Blue Cross Blue Shield of Texas - Transplant Programs
Care Improvement Plus - Medicare Advantage-SNP
Cenpatico - Medicaid-CHIP
Cenpatico - Medicaid-STAR
Cenpatico - Medicaid-STAR Health (Foster Care)
Cenpatico - Medicare Advantage
Cigna (USSA Client Only) - Direct Employer
Community First Health Plans - HMO/Exchange (EPO)
Community First Health Plans - Medicaid-CHIP
Community First Health Plans - Medicaid-CHIP Perinate
Community First Health Plans - Medicaid-STAR
Community First Health Plans - Medicaid-STAR Kids
Community First Health Plans - Medicare Advantage HMO
Coventry - HMO/PPO
Coventry - Work Comp / Auto
Driscoll Health Plan - Medicaid-All
EBSO - TPA
El Paso First - Medicaid-CHIP
El Paso First - Medicaid-STAR
Entrust - TPA
First Health - Commercial PPO
FirstCare (Part of Scott & White Health Plans) - Medicaid-STAR
Gonzaba Medical Group - Transplant ONLY
Healthsmart - Accel
Healthsmart - Commercial PPO
Healthsmart - HPO/POS
Humana - Commercial Behavioral Health
Humana - Exchange (HMOx)
Humana - HMO/PPO/Behavioral Health
Humana - Medicare Advantage Behavioral Health
Humana - Medicare Advantage HMO (Gold)
Humana - Medicare Advantage PPO
Humana - National Transplant ONLY Network
Humana Military - TRICARE
Imperial Health Plan - Medicare Advantage
Independent Medical Systems (IMS) - PPO
Interlink - Transplant
LifeTrac - Transplant
Magellan - Commercial and Medicaid Behavioral Health
Molina - Commercial Exchange
Molina - Medicaid-CHIP
Molina - Medicaid-CHIP Perinate
Molina - Medicaid-STAR
Molina - Medicare Advantage
Molina - Medicare-Medicaid Duals
OptumHealth - Transplant ONLY
Oscar - Commercial Exchange
Point Comfort Underwriters (PCU) - Refugee Medical Assistance
Point Comfort Underwriters (PCU) - Unaccompanied Children
Prime Health Services - Commercial PPO
Prime Health Services - Medicare Advantage
ProCare Advantage - Medicare Advantage I-SNP
Provider Network of America (PNOA) - Commercial
Provider Partners Health Plan (PPHP) - Medicare Advantage I-SNP
Scott & White Health Plan - HMO/PPO/Medicare Advantage
Superior HealthPlan - Medicaid-CHIP
Superior HealthPlan - Medicaid-CHIP Perinate
Superior HealthPlan - Medicaid-STAR
Superior HealthPlan - Medicaid-STAR Health (Foster Care)
Superior HealthPlan - Medicaid-STAR Kids
Superior HealthPlan - Medicaid-STAR PLUS
Superior HealthPlan - Medicare Advantage (Allwell)
Superior HealthPlan - Medicare-Medicaid Duals (Allwell)
Texas Independence Health Plan - Medicare Advantage I-SNP
Three Rivers Provider Network - PPO
Tokio Marine - Transplant
TriWest (via BCBSTX) - VA CCN Program
UnitedHealthcare - Medicaid-STAR
UnitedHealthcare - Medicaid-STAR Kids
UnitedHealthcare - Medicaid-STAR PLUS
UnitedHealthcare - Medicare Advantage
UnitedHealthcare - PPO
Universal Benefits Consortium - Brokerage Firm (School Districts)
University of Incarnate Word (Gilsbar) - Direct Employer
WellCare - Medicare Advantage
WellMed - Medicare Advantage
WellPoint (Gonzaba) - Medicare Advantage (TRANSPLANTS ONLY)
WellPoint - Medicaid-CHIP
WellPoint - Medicaid-CHIP Perinate
WellPoint - Medicaid-STAR
WellPoint - Medicaid-STAR Kids
WellPoint - Medicaid-STAR PLUS
WellPoint - Medicare Advantage
WellPoint - Medicare-Medicaid Duals
Please contact your health insurance company to confirm provider participation. For billing and insurance questions, please call our Billing Department at 210-358-3260.
I am Director of the Transplant Center at UT Health San Antonio and University Hospital. I received my medical degree at the University of Texas Medical School in Houston, Texas. I completed my residency and internship at New York University in New York City, New York, and my transplant fellowship at the University of Pittsburgh.
In 1992, I started the liver transplant program at UT Health San Antonio. I perform adult and pediatric liver and kidney transplants. Along with Dr. Francisco Cigarroa, I performed the first split liver transplant in South Texas. I also perform adult-to-adult living liver transplants and specialize in all liver, biliary and pancreas surgeries. I have also contributed to many notable publications in my field.

Abstracts

  1. Halff GA, Mansouri M, Poordad F, Lawitz E, Cigarroa F, Halff G, Lopez R, Alkhouri N. Characteristics and Outcomes of Liver Transplantation for Primary Biliary Cholangitis in Young patients: Analysis of the United Network for Organ Sharing Database Washington, DC.: 2017 Oct. (The Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)).
  2. Halff GA, Jay C, Pugh J, Abrahamian G, Cigarroa F, Washburn K. Graft quality matters: Survival after simultaneous liver-kidney transplant according to KDPI. 2017 May. (Clinical transplant; vol. 31, no. 5).
  3. Halff G, Amanda r. Munoz, Divya Chakravarthy, Jingjing Gong, Rita Ghosh, Addanki P. Kumar. Pancreatic Cancer: Current Status and Challenges Springer; 2017 Oct. (Current Pharmacology Reports; vol. 1).
  4. Halff GA, Jun Liu, Naoki Akanuma, Chengyang Liu, Ali Naji, Glenn A. Halff, William K. Washburn, Luzhe Sun & Pei Wang. TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells. 2016 Aug. (Scientific reports; vol. 6, no. 30904).
  5. Halff GA, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almenda J. Mora-Esteves C, Genyk Y, Holland B, Wilson DJ, Sher L, Koneru B. Parikh A. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era 2015 Sep. (Liver Transplant).
  6. Coronado, R, Kenneth, W, Ong, G, Halff GA, Christy, R. Effect of Decellularized Liver Matrix Proteins on Porcine Hepatocytes in vitro. 2014 Oct. (Biomedical Engineering Society Annual Meeting).
  7. Parikh A, Washburn WK, Matsuoka L, Pandit U, Genyk Y, Almeda JL, Mora-Esteves C, Halff GA, Kim J, Holland B, Wilson D, Sher L, Koneru B. Risk Factors for Number and Severity of Complications Following Deceased Donor Liver Transplantation 2014 Jun. p. 291. (Liver Transplantation; vol. 20).
  8. Coronado, R, Kenneth, W, Ong, J, Halff GA, Christy, R. Decellularized Liver Tissue Based Hydrogel for Repair and Regeneration. 2013 Apr. (Society For Biomaterials).
  9. Halff GA, McDiarmid S, Berquist W, Bucuvalas J, Narkewicz M, Millis J, Martin S, Mittal N, Atkison P, Fecteau A, Langnas A, Freese D, Kerkar N, Gilmour S, Fisher R, D‘Alessandro A, Eason J, Kane R, Alonso E, Tzakis A, Rosenthal P, Heffron T, Schwarz K, Andrews W, Lopez J, Bozorgzadeh A, Lowell J, Karpen S, Humar A, Gonzalez-Peralta R, Mazariegos G, Lavine J, Dunn S, Jonas M, Lobritto S, Telega G, Book L, Horslen S, Tector A, Tuttle- Newhall E. Long-term linear growth and puberty in pediatric liver transplant recipients. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL: J Pdiatr; 2013 Nov. p. 1354-1360. (The Journal of Pediatrics; vol. 163, no. 5).
  10. Halff GA, Narkewicz MR1, Green M, Dunn S, Millis M, McDiarmid S, Mazariegos G, Anand R, Yin W. Studies of Pediatric Liver Transplantation Research Group. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience. 2013 Jul. p. 730-740. (Liver Transplant; vol. 19, no. 7).
  11. Xiaoxin Mu, Shu Lin, Junhua Yang, Chen Chen, Yun Chen, Maryanne C. Herzig, Kenneth Washburn, Glenn A. Halff, Christi A. Walter, Beicheng Sun, Lu-Zhe Sun. TGF-β signaling is often attenuated during Hepatotumorigenesis but is retained for the malignancy of hepatocellular carcinoma cells. 2013 May. (Plos / One).
  12. Paez A.M., Kamath S., Casiraghi F., Davalli A., Abrahamian G.A., Ricotti A., Bastarrachea R., Commuzzie A., Owston M., Andreozzi F., Daniele G., Gaggini M., Fanti P., DeFronzo R., Gastaldelli A., Dick E., Halff G., Folli F.. Chronic exenatide infusion increases insulin sensitivity, decreases insulin secretion and stimulates islet proliferation in partially pancreatectomized non-human primates. 2012. (ADA Meeting).
  13. Halff GA, Vicky L. Ng MD, FRCP(C)1 Estella M. Alonso MD, John C. Bucuvalas MD, Geoff Cohen PhD, Christine A. Limbers PhD, James W. Varni, PhD, George Mazariegos MD, John Magee MD, Susan V. McDiarmid MD, Ravinder Anand PhD. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr; 2012 May. p. 820-826. (The Journal of Pediatrics; vol. 160, no. 5).
  14. Mu X, Herzig MC, Washburn WK, Walter CA, Halff GA, Sun L. TGF-ß signaling is frequently downregulated in hepatocellular carcinoma but is retained for malignant phenotype in some hepatocellular carcinoma cells 2012 Apr. (Abstract #3259, AACR 103rd Annual Meeting, Chicago, IL, March 31 - April 2012)..
  15. Kamath S, Chavez AO, Casiraghi, Cline G, Davalli A, Halff GA, Abrahamian G, Bastarrachea R, Comuzzie A, Gastaldelli A, Federici M, Marzano V, Urbani A, De Fronzo RA, Folli F.. Critical role of triglycerides and long chain fatty acyl Coa accumulation in liver insulin resistance in the baboon, a new non-human primate model of NAFLC 2011 Jan. p. S499-S499. (Journal of Hepatology; vol. 54, no. Suppl).
  16. Nguyen NTT, Ha CP, Harring TR, Chu D, Kar B, O‘Mahony C, Bakaeen F, Washburn WK, Halff GA, Goss JA, Speeg KV . Dilated Cardiomyopathy after Orthotopic Liver Transplantation: A Multi-Institution Report of Six Cases Treated with Mechanical Assist Devices 2011 Jan. (Hepatology; vol. 54, no. 661).
  17. Casiraghi F, Chavez AO, Davalli A, Abrahamian GA, Gastaldelli A, Bastarrachea R, Kamath S, Petz R, Zou P, Higgins P,Chang Z, Comuzzie A, Halff G, RALPH DeFronzo RA, Folli F. Effect of Continuous Exenatide Infusion on Insulin Action and Secretion in Partially Pancreatectomized Baboons 2011 Jan. (Diabetes; vol. Supp, no. 1).
  18. O’Mahony CA, Harring TR, Nguyen TT, Sussman NL, Washburn WK, Halff GA, Goss JA. Reconstruction Technique for In Situ Split-Liver Transplantation 2011 Apr. p. 340. (American Journal of Transplantation; vol. 11, no. s2).
  19. Lytvak I, Prihoda TJ, Speeg KV, Halff GA, Sharkey FE. Microsteatosis More Significant than Macrosteatosis in Predicting Early Post-Transplant Hepatic Non-Function 2010. p. 364A. (Modern Pathology; vol. 23).
  20. Cura M, Speeg KV, El-Merhi F, SURI R, Lopera JE, Washburn WK, Halff GA. Transjugular intrahepatic portosystemic shunts (TIPS) creation in recurrent hepatitis C (HCV) cirrhosis after Liver Transplantation (LT). 2010. (Cardiovascular and Interventional Radiology Society of Europe).
  21. Cura M, El-Merhi F, SURI R, Lopera JE, Speeg KV, Guerrero JA, Washburn WK, Halff GA. Transplant free survival (TFS) after Transjugular Intrahepatic Portosystemic Shunt (TIPS) creation with the Viatorr covered stent. 2010. (Cardiovascular and Interventional Radiological Society of Europe).
  22. Halff GA, Vicky Lee Ng, Annie Fecteau, Ross Shepherd, John Magee, John Bucuvalas, Estella Alonso, Suzanne McDiarmid, Geoff Cohen, Ravinder Anand. Outcomes of 5-Year Survivors of Pediatric Liver Transplantation: Report on 461 Children From a North American Multicenter Registry 2008 Dec. p. 1128-1135. (Pediatrics; vol. 122, no. 6).
  23. Feng S, Roberts J, Halff G, Washburn K. Factors Influencing Liver Transplant Length of Stay and Resource Utilization at Two Large Volume Transplant Centers 2007 Sep. p. 234a. (Hepatology; vol. 46, no. s1).
  24. Barshes NR, Washburn WK, Goss JA, Halff GA. Discrepancies In Deceased Donor Liver Allocation Within a Single Unos Region 2006 Aug. p. 785.
  25. Mejia A, Barshes NR, Goss JA, Washburn WK, Halff GA. Influence Of Deceased Donor Split Liver Grafts on The Pediatric Recipient’s Growth 2005 Jun. (Liver Transplantation; vol. 11, no. 7).
  26. Washburn WK, Nichols, L, Mejia A, Speeg KV, Halff GA. Recipient MELD Score and Resource Utilization: Higher is Higher. Presented at the American Transplant Congress, Seattle, WA: 2005 May. p. 425. (American Journal of Transplantation; vol. 5, no. s11).
  27. Washburn WK, Harper, A, Klintmalm, G, Goss, J, Halff GA. Regional Sharing for Status 1 Patients: Reduction in Waitlist Mortality. Presented at the American Transplant Congress, Seattle, WA: 2005 May. p. 263. (American Journal of Transplantation; vol. 5, no. s11).
  28. Mejia A, Saad A, Washburn K, Cigarroa F, Halff G. .Linear Growth of Pediatric Split Liver Recipients: Is There a Disadvantage? 2005 May. p. 339. (American Journal of Transplantation; vol. 5, no. s11).
  29. Pollack MS, Speeg KV, Callander NS, Freytes CO, Halff GA. Severe graft versus host disease manifesting eight months after liver transplantation 2004. p. S63-S63. (Human Immunology; vol. 65).
  30. Washburn WK, Halff G., Mieles L., Goldstein R., Goss J. Split Liver Transplantation: Statewide Usage of the Right Trisegmental Graft. Presented at the American Transplant Congress, Boston, MA: 2004 May. p. 437. (American Journal of Transplantation; vol. 4, no. s8).
  31. Washburn WK, Speeg KV, Guerrero JA, Havranek R, Esterl RM, Abrahamian GA, Cigarroa FG, Halff GA. MELD: Impact of Hepatocellular Carcinoma on the Adult Liver Transplant Waiting List 2003. p. 374A. (Hepatology; vol. 38).
  32. Pollack MS, Speeg KV, Nolan III CR, Washburn WK, Esterl RM, Abrahamian GA, Halff GA. Successful Combined Liver/Kidney Transplantation in Highly Sensitized, Crossmatch Positive Patients. 2002 Oct. p. S74. (Human Immunology; vol. 63, no. 10).
  33. Pollack MS, Havranek, R, Halff GA, Esterl RM, Washburn WK, Cigarroa FG, Speeg KV. Liver Transplant Recipients with Positive T-cell Crossmatches Have Excess Mortality. 2000 Oct. p. s91-s91. (Human Immunology; vol. 61, no. Sup 2).
  34. Salazar RM, Peters JI, Levine SM, Anzueto AR, Susanto I, Maxwell P, Sako EY, Halff GA. Evaluation of renal toxicity of amphotericin B lipid complex (ABLC) in solid organ transplant (SOT) patients 1999 Mar. p. A537. (Am J Respir Crit Care Med; vol. 159, no. 3).
  35. Elshihabi I, Halff GA, Calhoon JH, Kaspar D. Simultaneous heart and kidney transplant in a child 1995 Aug. (10th Congress of the International Pediatric Nephrology Association).
  36. Mohar DE, Bryan CL, Jenkinson SG, Anzueto AR, Peters JI, Levine SM, Halff GA. HLA matching as a predictor of OB or death in SLT 1993 Feb. p. 157S. (Chest; vol. 104, no. 2).

Book Chapters

  1. Espinoza A, Speeg KV, Washburn K, Halff G. Liver Transplantation In: Espinoza A, Speeg, Washburn K, Halff G. Essential Emergency Medicine for the Healthcare Practitioner. Saunders-Elsevier; 2007.
  2. Raheb J, Esterl RM, Washburn WK, Cigarroa FG, Halff GA. A Revisited Technique to Salvage Failed End to Side Radiocephalic Fistulae for Chronic Hemodialysis. In: Henry ML, Ed. Vascular Access for Hemodialysis VII. WL Gore and Access Medical Group, Ltd.; 2001. p. 01 - 02.
  3. Raheb J, Esterl RM, Washburn WK, Cigarroa FG, Halff GA. Ischemic Monomelic Neuropathy as a Complication of Forearm PTFE Loop Grafts in Uremic Diabetic Patients. In: Henry ML, Ed. Vascular Access for Hemodialysis VII. WL Gore and Access Medical Group, Ltd.; 2001. p. 001 - 002.
  4. Speeg VJ Jr, Halff GA, Schenker S. Metabolism of drugs before and after liver transplantation. In: Maddrey WC, Sorrell MF. Transplantation of the Liver, 3rd Edition. Philadelphia, PA: Lippencott, Williams & Wilkins; 2001.
  5. Dodd III GD, Halff GA, Rhim RC, Maldan MA. Thermal Ablation of Hepatic Tumors by Radiofrequency, Microwave, or Laser Therapy In: Blackwell Science Inc. 1999. p. 170 - 180.
  6. Speeg KV, Halff GA, Schenker S. Metabolism of Drugs Before and After Liver Transplantation In: Maddrey, Transplantation of the Liver. New York, NY: Elsevier; 1995.

Journal Articles

  1. Halff Glen A Ramon E. Coronado Maria Somaraki-Cormier Shanmugasundaram Natesan Robert J Christy Joo L Ong . Decellularization and Solubilization of Porcine Liver for Use as a Substrate for Porcine Hepatocyte Culture SAGE journals 2018 Feb;26(12):1840-1854.
  2. Parikh A, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almeda J, Mora-Esteves C, Halff G, Genck Y, Holland B, Wilson DJ, Sher L, Koneru B. A multi-center study of 30 days complications after deceased donor liver transplantation in the model for end stage liver disease score era. Liver Transplantation 2015 May;21(9):1160-1168.
  3. Halff GA, Fiorentino TV, Owston M, Abrahamian G, La Rosa S, Marando A, Perego C5, Di Cairano ES, Finzi G, Capella C, Sessa F, Casiraghi F, Paez A, Adivi A, Davalli A, Fiorina P, Guardado Mendoza R11, Comuzzie AG, Sharp M, DeFronzo RA, Dick EJ, Folli F. Chronic continuous exenatide infusion does not cause pancreatic inflammation and ductal hyperplasia in non-human primates. American Journal of Pathology 2015 Jan;185(1):139-150.
  4. Mu X, Lin S, Yang J, Chen C, Herzig MC, Washburn WK, Halff GA, Walter CA, Sun B, Sun L. TGF-ß signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells Plos One 2013 May;8(5):e63436.
  5. Paez AM, Kamath S, Casiraghi F, Davalli AM, Abrahamian G, Ricotti A, La Rosa S, Comuzzie A, Marando A, Finzi G, Dick E, De Fronzo R, Halff GA, Folli F. Chronic exenatide infusion increases insulin sensitivity, decreases insulin secretion and stimulates islet cell proliferation in partially pancreatectomized baboons. Diabetologia 2012;55(Suppl): S291.
  6. Kamath S, Chavez AO, Gastaldelli A, Casiraghi F, Halff GA, Abrahamian GA, Davalli AM, Bastarrachea RA, Comuzzie AG, Guardado-Mendoza R, Jimenez-Ceja LM, Mattern V, Paez AM, Ricotti A, Tejero ME, Higgins PB, Rodriguez-Sanchez IP, Tripathy D, Defronzo RA, Dick EJ, Cline GW, Folli F. Coordinated defects in hepatic long chain Fatty Acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates. PLoS One 2011 Nov;6(11):27617-27617.
  7. Casiraghi F, Chavez AO, Davakku A, Abrahamian GA, Gastaldelli A, Bastarrachea R, Kamath S, Petz R, Zou P, Hibbins P, Chang Z, Comuzzie A, Halff GA, Defronzo RA, Folli F. Effect of continuous exenatide infusion on insulin action and secretion in partially pancreatectomized baboons. Diabetes 2011;(Suppl).
  8. Halff GA, Washburn K. Hepatocellular carcinoma and liver transplantation Curr Opin Organ Transplant 2011 Jun;16(3):297-300.
  9. Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Hum Pathol 2011 Sep;42(9):1337-1342.
  10. Martin SR, Alvarez F, Anand R, Song C, Yin W. Outcomes in children who underwent transplantation for autoimmune hepatitis. Liver Transplant 2011 Apr;17(4):393-401.
  11. Halff GA, Guiteau JJ, Cotton RT, Washburn WK, Harper A, O'Mahony CA, Sebastian A, Cheng S, Klintmalm G, Ghobrial M, Mieles l, Goss J. An Early regional experience with expansion of Milan Criteria for liver transplant recipients American Journal of Transplant 2010 Sep;10(9):2092-8098.
  12. Halff GA, Wang Y, Speeg KV, Washburn WK. Sirolimus Plus Sorafenib in Treating HCC Recurrence after Liver Transplantation: A Case Report World Journal of Gastroenterology 2010 Nov;16(43):5518-5522.
  13. Halff GA, Yubao Wang, Kermit V Speeg, William Kenneth Washburn. Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: a case report. World Journal of Gastroenterology 2010 Nov;16(43):5518-5522.
  14. Washburn W, Meo N, Halff GA, Roberts JP, Feng S. Factors Influencing Liver Transplant Length of Stay at Two Large-Volume Transplant Centers Liver Transplantation 2009;15:1570-1578.
  15. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transplant 2009 Nov;15(11):1570-1578.
  16. Guardado-Mendoza R, Davalli AM, Chavez AO, Hubbard GB, Dick EJ, Majluf-Cruz A, Tene-Perez CE, Perego C, Goldschmidt L, Hart J, Comuzzie AG, Tejero ME, Finzi G, Pacidi C, LaRosa S, Capela C, Halff G, Gastaldelli A, Defronzo RA, Foli F. Pancreatic Islet Amyloidosis, Beta Cell Apoptosis, and Alpha Cell Proliferation are Determinants of Islet Remodeling in Type 2 Diabetic Baboons Proc Natl Acad Sci USA 2009 Aug;106(33):13992-13997.
  17. Halff GA, Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, McDiarmid S, Cohen G. Outcomes of 5-year Survivors of Pediatric Liver Transplantation: Report on 461 Children from a North American Multicenter Registry Transplantation Research Group 2008 Dec;122(6):1128-1135.
  18. Barshes NR, Becker NS, Washburn WK, Halff GA, Aloia TA, Goss JA. Geographic disparities in deceased donor liver transplantation within a single UNOS region. Liver Transplant 2007 May;13(5):747-751.
  19. Halff GA, Mejia A, Barshes N, Goss J, Washburn WK. Use of Split-Liver Allografts Does Not Impair Pediatric Recipient Growth Liver Transplantation 2007 Jan;13(1):145-148.
  20. Halff G, Washburn WK, Pollock BH, Nichols L, Speeg KV. Impact of recipient MELD score on resource utilization American Journal Transplant 2006 Oct;6(10):2449-2454.
  21. Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, Abrahamian GA, Washburn WK, Halff GA. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis. Hum Immunol 2005 Jan;66(1):28-31.
  22. Lee TC, Barshes NR, Washburn WK, Halff GA, Carter BA, Karpen SJ, Bristow LJ, Scott JD, Goss JA. Split-liver transplantation using the left lateral segment: a collaborative sharing experience between two distant centers. Am J Transplant 2005 Jul;5(7):1646-1651.
  23. Washburn K, Halff G, Mieles L, Goldstein R, Goss JA, Halff GA. Split-liver transplantation: results of statewide usage of the right trisegmental graft. Am J Transplant 2005 Jul;5(7):1652-1659.
  24. Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode. Liver Transplantation 2004 Mar;10(3):369-373.
  25. Cigarroa FG. Liver Transplantation at The University of Texas Health Science Center/University Hospital in San Antonio Clinical Transplants 2004:247-253.
  26. Washburn WK, Dodd GD III, Kohlmeier RE, McCoy VA, Napier DH, Hubbard LG, Halff GA, Esterl RM, Cigarroa FG, Sharkey FE. Radiofrequency tissue ablation: effect of hepatic blood flow occlusion on thermal injuries produced in cirrhotic livers. Ann Surg Oncol 2003 Aug;10(7):773-777.
  27. Cigarroa FG. Radiofrequency tissue ablation: effect of hepatic blood flow occlusion on thermal injuries produced in cirrhotic livers. Ann Surg Oncol 2003 Aug;10(7):773-777.
  28. Jones WT, Ratner I, Abrahamian G, Washburn WK, Esterl R, Neigut D, Halff G. Use of a SILASTIC Silo for Closure of the Abdominal Wall in a Pediatric Patient Receiving a Cadaveric Split Liver. J Pediatric Surgery 2003 Oct;38(10):E20-22.
  29. Nunez A, Goodpastor SE, Goss JA, Washburn WK, Halff GA.Enlargement of the cadaveric-liver donor pool using in-situ split-liver transplantation despite complex hepatic arterial anatomy. Transplantation 2003 Oct;76(7):1134-1136.
  30. Mejia A, Halff GA, Esterl R, Cigarroa F, Speeg KV, Villarreal R, Washburn K. Outcome of Liver Transplantation in Hispanics versus Non-Hispanics: Is There a Difference? Transplant Proc 2002 Jun;34(4):1236-1238.
  31. Cigarroa FG. Sonographically Observed Echogenic Response during Intraoperative Radiofrequency Ablation of Cirrhotic Livers: Pathologic Correlation American Journal of Radiology 2002 May;178(5):1147-1151.
  32. Leyendecker JR, Dodd GD, Halff GA, McCoy VA, Napier DH, Hubbard LG, Chintapalli KN, Chopra S, Washburn WK, Esterl RM, Cigarroa FG, Kohlmeier RE, Sharkey FE. Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation. AJR Am J Roentgenol 2002 May;178(5):1147-1151.
  33. Bingener-Casey J, Esterl RM, Kenneth Washburn W, Cigarroa FG, Abrahamian GA, Halff GA. Tc-99m-labeled Red Blood Cell Scanning Localizes Anastomotic Hemorrhage Between the Distal Ileum and Duodenal Stump of an Enteric-drained Pancreas Transplant. Clin Nucl Med 2002 Mar;27(3):205-206.
  34. Cigarroa FG. Outcome of Liver Transplantation in Hispanics Versus Non-Hispanics: Is there a Difference? Transplantation Proceedings 2001 Feb;34:1236-1238.
  35. Cigarroa FG. Steroid elimination 24 hours after Liver Transplantation using daclizumab, tacrolimus, and mycophenolate mofetil Transplantation 2001 Nov;72(10):1675-1679.
  36. Washburn K, Speeg KV, Esterl R, Cigarroa F, Pollack M, Tourtellot C, Maxwell P, Halff G. Steroid Elimination 24 hours After Liver Transplantation Using Daclizumab, Tacrolimus, and Mycophenolate Mofetil. Transplantation 2001 Nov;72(10):1675-1679.
  37. Patterson JE, Peters J, Calhoon JH, Levine S, Anzueto A, Al-Abdely H, Sanchez R, Patterson TF, Rech M, Jorgensen JH, Rinaldi MG, Sako E, Johnson S, Speeg V, Halff GA, Trinkle JK. Investigation and Control of Aspergillosis and Other Filamentous Fungal Infections in Solid Organ Transplant Recipients Transpl Infect Dis 2000 Mar;2(1):22-28.
  38. Sabo B, Dodd III GD, Halff GA, Naples JJ. Anesthetic considerations in patients undergoing percutaneous radiofrequency interstitial tissue ablation. AANA J 1999 Oct;67(5):467-468.
  39. St Laurent M, Esterl RM, Halff GA, Speeg KV. Gallbladder Carcinoma Producing Alpha-fetoprotein. J Clin Gastroenterol 1999 Mar;28(2):155-158.
  40. Rhim R, Dodd III GD, Halff GA. Ultrasound Guided Thermal Ablation of Malignant Hepatic Tumors. Ultrasound Quarterly 1999;15:93-102.
  41. St Laurent M, Surendranath C, Saad T, Halff G, Esterl R. A New Salvage Procedure for Peritoneal Dialysis Catheters with Exit Site Infections. Am Surg 1998 Dec;64(12):1215-1217.
  42. Cai TH, Esterl RM, Nichols L, Cigarroa F, Speeg KV, Halff GA. Improved Immunosuppression with Combination Tacrolimus (FK506) and Mycophenolic Acid in Orthotopic Liver Transplantation. Transplant Proc 1998 Jun;30(4):1413-1416.
  43. Lahiri SA, Halff GA, Speeg KV, Esterl RM. Indium-111 WBC Scan Localizes Infected Hepatic Cysts and Confirms Their Complete Resection in Adult Polycystic Disease. Clin Nucl Med 1998;23(1):33-34.
  44. Halff GA. Liver Transplants Becoming Routine San Antonio Medicine 1998 Nov;51(11):16-16.
  45. Stephenson K, Gupta A, Mustafa SB, Halff GA. Endothelin-Stimulated Nitric Oxide Production in the Isolated Kupffer Cell Journal of Surgical Research 1997;73:149-154.
  46. Felger J, Halff GA, Esterl RM. Exposure to Mycobacterium tuberculosis (MTB) in a Renal Transplant Candidate: What Further Preoperative Screening Tests are Available? Clin Transplant 1997 Apr;11(2):142-148.
  47. Freyaldenhoven S, Halff GA, Esterl RM. Reflux into Redundant Duodenal Stump of Pancreatic Allograft Imitates Duodenal Stump Leak on Tc-99m MAG3 Scintigraphy. Clin Nucl Med 1997 May;22(5):338-339.
  48. Esterl RM, St Laurent M, Bay MK, Speeg KV, Halff GA. Stent Migration and Small Bowel Perforation After Endoscopic Biliary Stent Placement in a Liver Transplant Recipient. J Clin Gastroenterol 1997 Mar;24(2):106-110.
  49. Halff GA, Esterl RM, Speeg KV. The Use of Cellcept to Minimize Prograf Toxicity in Early Post-operative Liver Transplant Patients with Renal Insufficiency. J Hepatology 1996;25:203-203.
  50. Marvin RG, Halff GA, Elshihabi I. Renal Allograft Torsion Associated with Prune Belly Syndrome Pediatric Nephrology 1995;9(1):81-82.
  51. Marvin RG, Halff GA, Elshihabi I. Renal allograft torsion associated with prune-belly syndrome. Pediatr Nephrol 1995 Feb;9(1):81-82.
  52. Esterl RM, Halff GA. The Use of Methylene Blue in the Identification of Lymphoceles after Renal Transplantation. Urology 1995 Jun;45(6):1088-1089.
  53. Stephenson K, Halff GA. Endothelin Stimulates Nitric Oxide Production in the Isolated Rat Kupffer Cell FASEB J 1994;A924.
  54. Schenker S, Halff GA. Nutritional Therapy in Alcoholic Liver Disease Seminars in Liver Disease 1993;13:196-209.
  55. Schenker S, Halff GA. Nutritional therapy in alcoholic liver disease. Semin Liver Dis 1993 May;13(2):196-209.
  56. Harris LJ, Crooke GA, Grossi EA, Teperman LW, Halff GA, Galloway AC, Spencer FC, Weil R. Anatomic distribution of preservation solutions during canine hepatic procurement. Transplant Proc 1991 Oct;23(5):2430-2431.
  57. Teperman LW, Baumann FG, Harris L, Crooke G, Halff GA, Weil R. Improved arterial allograft preservation with the University of Wisconsin solution. Transplant Proc 1991 Feb;23(1 Pt):896-898.
  58. Toth A, Abdallah HY, Venkataramanan R, Teperman L, Halff GA, Rabinovith M, Burckhart GJ, Starzl TE. Pharmacokinetics of Ceftriaxone in Liver Transplant Recipients Journal of Clinical Pharmacology 1991;8:722-728.
  59. Halff GA, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver Transplantation for the Budd-Chiari Syndrome Ann Surg 1990;211:43-49.
  60. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE, Halff GA. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990 Jan;211(1):43-49.
  61. Teperman L, Halff GA, Tzakis AG. Peritoneovenous Shunting vs. Medical Treatment in Patients with Alcoholic Cirrhosis and Massive Ascites NEJM 1990;322:1750-1750.
  62. Halff G, Todo S, Hall R, Starzl TE, Halff GA. Late complications with gallbladder conduit biliary reconstruction after liver transplantation. Transplantation 1989 Sep;48(3):537-539.
  63. Halff GA, Todo S, Hall R, Starzl TE. Late Complications with the Gallbladder Conduit Biliary Reconstruction After Liver Transplantation 1989;49:537-539.

Other Publications

  1. Esterl RM, Washburn WK, Halff GA. UTHSCSA and Liver, Kidney and Pancreas Transplantation. San Antonio Medicine 2005 Feb;58(2):32-33.
  2. Bready LL, Rasch DK, Halff GA, Elshihabi, I, Gamboa, C. Renal Transplantation for the Pediatric Patient In: Clinical Protocols for the UTHSCSA Department of Anesthesiology 1995 Feb.
  3. Coppa GF, Halff GA. Prediction of Outcome in Critically Ill Patients Intensive Care and Emergency Med 1992:673-681.
  4. Halff GA. "Pancreatic Cancer: Current Status and Challenges" Current Pharmacology Reports.
Call 210-743-4306 to request an appointment with this doctor.
Back to Search
Patient reviews

    Download Our Mobile App

    Access health information, get turn-by-turn navigation in University Hospital, find a doctor or location, and more.
    Learn more